Butanamide,N-[[(6S,7R,9R,14aS,15R)-7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl]methyl]-2-oxo-
| Product Information | |
|---|---|
| Product Number: | AX-DUX3 |
| Product Name: | Butanamide,N-[[(6S,7R,9R,14aS,15R)-7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl]methyl]-2-oxo- |
| CAS: | 107140-33-0 |
| MW: | 0 |
| Synonyms: | Butanamide,N-[(7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl)methyl]-2-oxo-,[6S-(6a,7a,9b,14aa,15a)]-; 6,15-Imino-4H-isoquino[3,2-b][3]benzazocine,butanamide deriv.; Saframycin Ad 1 |
| EINECS: | |
| Density: | 1.41g/cm3 |
| Melting Point: | |
| Boiling Point: | °Cat760mmHg |
| Flash Point: | °C |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |